Type 2 immune response associated with silicosis is not instrumental in the development of the disease.

Misson, Pierre-Damien;Brombacher, Frank;Delos, Monique;Lison, Dominique;Huaux, François
(2007) American Journal of Physiology: Lung Cellular and Molecular Physiology — Vol. 292, n° 1, p. L107-13 (2007)

Files

pdfdocument.pdf
  • Restricted Access
  • Adobe PDF
  • 2 KB

Details

Authors
  • Misson, Pierre-DamienUCLouvain
    Author
  • Brombacher, Frank
    Author
  • Author
  • Lison, Dominiqueorcid-logoUCLouvain
    Author
  • Author
Abstract
It has been proposed that the development of lung fibrosis is associated with a T helper type 2 response, mainly characterized by IL-4 and IL-13 production. We investigated the potential role of type 2 immune polarization in the silicotic process and examined the pulmonary response to silica particles in mice genetically deficient for IL-4. We found that IL-4(-/-) mice were not protected against the development of silicosis, suggesting that IL-4 is not essential for the development of this fibrotic disease. By evaluating the intensity of silica-induced lung fibrosis in mice deficient for IL-4 receptor alpha (IL-4Ralpha), we showed that the establishment of pulmonary fibrosis was independent of both IL-4 and IL-13. Strong impairment of the type 2 immune response (IgG(1)) in the lungs of IL-4(-/-) and IL-4Ralpha(-/-) mice did not affect the development of the disease. Measurement of IL-13alpha2 receptor expression and IgG(2a), IL-12p70, and IFN-gamma levels in silica-treated IL-4(-/-) and IL-4Ralpha(-/-) animals showed that the development of silicosis was not related to an IL-13 signaling pathway or a switch to a type 1 response in deficient animals. Our data clearly indicate that the type 2 immune response associated with silicosis in mice is not required for the development of this inflammatory and fibrotic disease.
Affiliations

Citations

Misson, P.-D., Brombacher, F., Delos, M., Lison, D., & Huaux, F. (2007). Type 2 immune response associated with silicosis is not instrumental in the development of the disease. American Journal of Physiology: Lung Cellular and Molecular Physiology, 292(1), L107-13. https://doi.org/10.1152/ajplung.00503.2005 (Original work published 2007)